In situ Formed Implants, Based on PLGA and Eudragit Blends, for Novel Florfenicol Controlled Release Formulations
نویسندگان
چکیده
Drug controlled release technologies (DCRTs) represent an opportunity for designing new therapies. Main objectives are dose number optimization and secondary effects reduction to improve the level of patient/client acceptance. The present work studies DCRTs based in blended polymeric implants single long-term therapies florfenicol (FF), a broad spectrum antibiotic. Polymers used were PLGA Eudragit E100/S100 types. Eudragit/PLGA FF/PLGA ratios main studied factors terms encapsulation efficiencies (EEs) drug profiles. In addition, morphological physicochemical characterization carried out. EEs 50–100% depending on formulation composition, FF releasing rate was increased or diminished when E100 S100 added, respectively. hydrolytic cleavage products possibly affect solubility matrix stability. Different mathematical models better understanding simulating processes. Implants maintained antimicrobial activity against Pseudomonas aeruginosa up 12 days agar plates. developed represents suitable alternative
منابع مشابه
Novel Carbopol – Wax Blends for Controlled Release Oral Dosage Forms
ii ACKNOWLEDGEMENTS I would like to thank my major professor, Dr. Atul J. Shukla for his valuable support and guidance. I would also like to thank my committee members, Dr. for their valuable suggestions and guidance. I would also like to thank my present lab colleagues Dr. for their guidance and help. I thank my parents, wife and sister for supporting me at all times. My success has always bee...
متن کاملInvestigation of in situ gelling alginate formulations as a sustained release vehicle for co-precipitates of dextromethrophan and Eudragit
Accepted September 16, 2013 Alginate vehicles are capable of forming a gel matrix in situ when they come into contact with gastric medium in the presence of calcium ions. However, the gel structure is pH dependent and can break after gastric emptying, leading to dose dumping. The aim of this work was to develop modified in situ gelling alginate formulations capable of sustaining dextromethorpha...
متن کاملStudy of Release Kinetics of Dexamethasone from Biodegradable Plga In-situ Implants
The primary objective of this study is to evaluate the effect of drug loading and the effect of excipients on the release pattern of Dexamethasone Sodium Phosphate from in situ PLGA implants formed in vitro in gelatin gel. This system is prepared by dissolving a biodegradable polymer (DL-PLGA 70K) in dimethyl sulfoxide (DMSO). Then the drug with excipients or without excipients was added to it....
متن کاملBioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading
Poly(lactic-co-glycolic acid) (PLGA) is the most widely used biomaterial for microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens. PLGA has excellent biodegradability and biocompatibility and is generally recognized as safe by international regulatory agencies including the United States Food and Drug Administration and the European Medicines Agency. The physico...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pharmaceutical Sciences
سال: 2021
ISSN: ['0022-3549', '1520-6017']
DOI: https://doi.org/10.1016/j.xphs.2020.11.006